Ligand Pharmaceuticals Incorporated's Suppliers Performance

Name: Ligand Pharmaceuticals Incorporated's (LGND) Suppliers by Company, Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

LGND's Supply Chain

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


LGND Costs vs Sales of Suppliers Growth		Ligand Pharmaceuticals Incorporated's cost of sales deteriorated by -1.95 % year on year, relative to one quarter ago cost of sales fell by 0 % in Q2. • More on LGND Suppliers

Ligand Pharmaceuticals Incorporated's cost of sales deteriorated by -1.95 % year on year, compare to one quarter ago cost of sales fell by 0 % in Q2.

• More on LGND Suppliers

Select the Relationship:

Suppliers ▼

Select the Category:

Comparison ▼

Suppliers ▼

Basic Report▼

Ligand Pharmaceuticals Incorporated's Comment on Supply Chain

The company has a supply agreement with Hovione for Captisol, initially set to expire in December 2024 and automatically renewed through December 2026 with successive two-year renewal terms. Either party may terminate the agreement with written notice at least two years before the renewal term's expiration or for reasons such as uncured material breach, bankruptcy, extended force majeure events, extended supply interruptions, or regulatory actions related to Captisol. The company has ongoing minimum purchase commitments under this agreement. In the event Hovione cannot supply Captisol due to an uncured force majeure event, the company may source Captisol from third parties previously identified. The Captisol business may face competition from other suppliers of similar cyclodextrin excipients or technologies designed to enhance the solubility or stability of active pharmaceutical ingredients.

Ligand Pharmaceuticals Incorporated's Comment on Supply Chain

LGND's Stock Perfrormance relative to it's Suppliers

LGND's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Ligand Pharmaceuticals Incorporated	6,530.14	290.54	197.22	47
SUBTOTAL	0.00	0.00	0.00	-

Sources: Ligand Pharmaceuticals Incorporated's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on: Friday, September 18, 2026 5:21 PM
For your research, we’ve provided nine additional tables on Ligand Pharmaceuticals Incorporated’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.